SAB Biotherapeutics, Inc. Warrant

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SABSW and buy or sell other stocks, ETFs, and their options commission-free!

About SABSW

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. 

CEO
Samuel J. Reich
CEOSamuel J. Reich
Employees
—
Employees—
Headquarters
Miami Beach, Florida
HeadquartersMiami Beach, Florida
Founded
2014
Founded2014
Employees
—
Employees—

SABSW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
16.59K
Average volume16.59K
High today
$0.0251
High today$0.0251
Low today
$0.0251
Low today$0.0251
Open price
$0.0251
Open price$0.0251
Volume
506.00
Volume506.00
52 Week high
$0.18
52 Week high$0.18
52 Week low
$0.0206
52 Week low$0.0206

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.